QVR’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,500
Closed -$488K 53
2026
Q1
$488K Buy
+3,500
New +$490K 0.02% 88
2023
Q1
Sell
-1,600
Closed -$137K 70
2022
Q4
$137K Sell
1,600
-27,400
-94% -$2.17M 0.02% 126
2022
Q3
$1.79M Buy
29,000
+15,000
+107% +$946K 0.15% 120
2022
Q2
$865K Sell
14,000
-30,500
-69% -$1.89M 0.06% 205
2022
Q1
$2.65M Buy
44,500
+44,400
+44,400% +$2.84M 0.1% 191
2021
Q4
$7K Sell
100
-20,500
-100% -$1.41M ﹤0.01% 14
2021
Q3
$1.44M Buy
20,600
+15,800
+329% +$1.11M 0.09% 165
2021
Q2
$331K Buy
4,800
+2,300
+92% +$154K 0.03% 213
2021
Q1
$161K Buy
+2,500
New +$161K 0.01% 151

Other funds holding GILD

QVR's GILD Position: Q2 2026 in Review

QVR sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 22 shares — an estimated $3.07K sold.

QVR first reported a position in GILD in Q1 2021 and held it in 8 quarters. The position peaked at $254K in Q4 2025. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • QVR reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • QVR sold 22 Gilead Sciences shares in Q2 2026, an estimated $3.07K.
  • QVR first reported a position in Gilead Sciences in Q1 2021 and held it in 8 quarters.
  • QVR's Gilead Sciences position peaked at $254K in Q4 2025.
  • 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on QVR's 13F filing for Q2 2026.